Concepedia

Sophia R. Majeed

SR

Statistics

Publications

9

Citations

299

H-Index

9

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

University of California, San Francisco

San Francisco Foundation

Sophia R. Majeed is an author at Gilead Sciences (United States) specializing in pharmacy, antiviral therapy, and life sciences.

Publications per year

2012–2023

9

Publications

9

Resistance Analysis of Bictegravir-Emtricitabine-Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients through 48 Weeks

Rima Acosta, Madeleine Willkom, Ross Martin et al. · Antimicrobial Agents and Chemotherapy · 2019 · 60 citations · Full text

, , +17

Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG

Amy B. Foraker, Stéphane M. Camus, Timothy Evans et al. · The Journal of Cell Biology · 2012 · 54 citations · Full text

, , +17

Clathrin light chains are required for the gyrating-clathrin recycling pathway and thereby promote cell migration

Sophia R. Majeed, Lavanya Vasudevan, Chih‐Ying Chen et al. · Nature Communications · 2014 · 52 citations · Full text

, , +17

Clathrin light chains’ role in selective endocytosis influences antibody isotype switching

Shuang Wu, Sophia R. Majeed, Timothy Evans et al. · Proceedings of the National Academy of Sciences · 2016 · 37 citations · Full text

, , +17

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial

Joseph J. Eron, Jean‐Daniel Lelièvre, Robert C. Kalayjian et al. · The Lancet HIV · 2018 · 33 citations

, , +17

1–5 of 9